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Maximal plasma creatine kinase (CPK) values are often used as an
enzymatic test in acute myocardial infarction. The cardiovascular
functional ability (FA) is a reliable parameter, which may define
the lesion of the cardiovascular system following myocardial infarc-
tion. We have applied the Cubist machine learning tool to set up a
model that defines the residual cardiovascular functional ability
after a myocardial infarction by means of the maximal CPK in the
acute phase of the disease. Cubist models numeric data and gener-
ates values by means of a collection of rules associated with the lin-
ear expression for computing target values. Based on the literature
data set of Miri} et al.,1 we have derived and tested a reliable and
accurate Cubist model for acute inferior and anteroseptal myocar-
dial infarction consisting of three simple rules. The rules enable
simple prediction of the expected cardiovascular functional ability
in myocardial infarction following recovery. The model is based on
two clinical parameters related to the disease, maximal CPK in the
acute phase of the myocardial lesion, and anteroseptal or inferior
cardial localisation of the infarction. Strong correlation (r antero-
septal = 1.00, r inferior = 0.94, n = 56), insignificant differences of
real and predicted values, and low average error of the leave-one-
out test (anteroseptal 1.72, inferior 3.54) confirm the accuracy of
the method and its applicability in clinical medicine. In addition to
the prognostic and diagnostic application, the extracted rules en-
able more efficient evaluation of new drugs and therapeutic proce-
dures in Cardiology.
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INTRODUCTION
Heart disease has become a major health hazard in middle life and in
old age. Myocardial infarction, as a consequence of the heart disease, usu-
ally leads to a number of complications resulting in a decreased cardiovas-
cular functional ability (FA). In this study, we model the relationship of plas-
ma creatine kinase levels (CPK) and decreased cardiovascular functional
ability in anteroseptal and inferior infarction. These two localisations are
found in 80% of all patients with myocardial infarction.1
Determination of maximal CPK values reflects the degree of myocardial
damage at the beginning of infarction, and cardiovascular functional ability
defines the capacity of the cardiovascular system following the recovery.1,2
We applied the Cubist machine learning tool to predict the decrease of car-
diovascular functional ability on the basis of maximal CPK levels in acute
anteroseptal and inferior myocardial infarction. The latter is important for
the prediction of the heart disease outcome following the infarction, and for
the evaluation of new therapeutic procedures in Cardiology.
MATERIAL AND METHODS
Data Set and Measurements
The analysed data set for modelling the relationship of CPK values and cardio-
vascular functional ability (FA) in myocardial infarction was obtained from the data
presented in Figure 2 and Figure 3 of Miri} et al.1 using of the Origin software (www.
OriginLab.com), which is capable of extracting data coordinates from imported pic-
tures. A total of 56 different cases of anteroseptal and inferior infarction localisa-
tions were extracted from the figures. Maximal CPK values in iU L–1 were measured
in the standard manner, every 8 hours during the first 48 hours of acute myocardial
infarction.1–6 The cardiovascular functional ability, expressed as the percentage of
oxygen uptake (FA in %), was measured on a tread-mill according to the Bruce proto-
col in the same patients with anteroseptal or inferior localisation of myocardial in-
farction 4 months after the onset of the disease (and CPK determination).1–6
Cubist Machine Learning System
The Cubist machine learning system, version 1.09 (www.Rulequest.com), was
used for the generation of a rule-based predictive model of CPK and cardiovascular
functional ability (FA) in anteroseptal and inferior myocardial infarction. In contrast
to its sister model C5.0 (outgrowth of the classic C4.5) that predicts categories,7–9
Cubist models numeric data and generates values. It extracts the collection of rules,
each of which is associated with a linear expression for computing target values.
Therefore, the Cubist model resembles a piecewise linear model (except that the ru-
les can sometimes overlap). Cubist can also construct multiple models and combine
rule-based models with instance-based (nearest neighbour) models. The Cubist ap-
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plication consists of a collection of text files that define attributes, describe the ana-
lysed cases and provide new cases to test the produced models.
RESULTS AND DISCUSSION
The prognostic value of CPK determination in acute myocardial infarc-
tion was observed considering its influence on the cardiovascular functional
ability and the localisation of infarction (Table I). Maximal CPK values in
acute myocardial infarction are thought to be a reliable laboratory enzymatic
parameter that defines the myocardial damage.1,2 Normal CPK values are
10–15 iU L–1 and in myocardial infarction CPK are often >10 times higher
than in the controls.2,6
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TABLE I
Training set of the maximal plasma creatine kinase (CPK / iU L–1) values and
cardiovascular functional ability (FA / %) in anteroseptal and inferior myocardial
infarction. The data were extracted from Miri} et al.1 by means of the Origin
software. The Cubist machine learning system release 1.09 was used to (a) define
the prognostic value of CPK levels measured in acute anteroseptal and inferior
myocardial infarction, (b) predict the cardiovascular functional ability following
the recovery (FAC). Rules of the models are presented in Table II.
Anteroseptal Infarction Inferior Infarction
CPK† / iU L–1 FA§ / % FAC* / % CPK† / iU L–1 FA§ / % FAC* / %
484 94.9 95.3 320 96 83.4
492 94.9 93.9 326 89.7 83.9
502 95 92.3 337 84.8 84
496 89.7 93.8 353 84.9 82.6
508 84.4 84.8 305 82 86.2
518 84.6 83.4 324 79.9 85.4
532 79.7 81.9 357 79.8 83.1
544 79.7 80.2 392 74.9 80.6
564 77.8 77.8 451 74.6 76.5
578 69.5 68.5 465 74.9 75.6
588 69.5 68.1 471 71.7 67.5
598 69.5 68 522 68.8 68
584 67.5 68.6 549 68 67.7
705 66.3 66.4 569 67.7 68
750 64.8 65.6 677 67.7 65.9
The Cubist based rules that define the relationship of maximal CPK val-
ues and the remaining cardiovascular functional ability following the recov-
ery of anteroseptal and inferior myocardial infarction are presented in Table
II. Table I presents the results of individual functional ability values and
those predicted from the maximal CPK during the acute phase of the dis-
ease. The accuracy and applicability of the prediction method are confirmed
by the insignificant differences, strong correlations and low error rates of
the leave-one-out cross-validation tests, when the real and predicted cardio-
vascular functional ability data are compared (Table I, Figure 1).
The Cubist rule based model confirms that anteroseptal infarction is as-
sociated with a greater decrease in functional ability than the inferior one
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Anteroseptal Infarction Inferior Infarction
CPK† / iU L–1 FA§ / % FAC* / % CPK† / iU L–1 FA§ / % FAC* / %
794 64.6 64.6 686 67.7 65.7
867 63.6 63.8 686 64.8 66.3
1000 61.5 60.6 702 64.8 66.2
1020 59.7 60.8 753 64.7 65.4
1139 59.8 58.7 822 64.6 64.6
1208 57.4 57.5 878 64.6 64
1242 57.4 56.8 914 64.6 64
1278 56.4 56 1180 64.6 66.2
1290 54.6 56.3 1259 64.6 64.1
1478 54.5 54.8 1277 64.6 63.5
1524 54.3 54 2035 43 43.4
1571 54.2 53.8 – – –
1685 53 52 – – –
1825 48.9 50.5 – – –
1934 48.8 48.5 – – –
x 943.27 67.88 67.91 677.31 71.46 71.22
SD 456.66 14.20 14.25 401.42 10.71 10.10
r** 1 0.94
* Predicted by Cubist from CPK of the myocardial infarction localisations.
† p = 0.0255 (t = –2.30).
§ FA and FAC* groups do not differ (p > 0.93, t < 0.25).
** Correlated to FA.
TABLE I (cont.)
(Table I), which is in line with the previously observed results of [tambuk5,6
for the nonlinear hyperbolic model of CPK and cardiovascular functional
ability in infarction. This may be partly due to the extensive necrosis with
higher deterioration in the left ventricular contractility.1 Therefore, our re-
sults obtained by the Cubist based rules confirm that the site of infarction is
a contributing factor responsible for the cardiovascular functional ability re-
maining after the recovery. The latter is also confirmed by 96.43% accurate
discrimination of cases with anteroseptal and inferior infarction localisa-
tions obtained for CPK and functional ability parameters by means of the
classification tree (Figure 2).
Low misclassification error rates of the tree, and the jack-knife test con-
firm the validity of the tree and parameter dependence (Figure 2). Tree-ba-
sed models are statistical procedures that provide an alternative to linear
and additive models for regression problems and to linear and additive lo-
gistic models for classification problems.10 The rules are obtained by recur-
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TABLE II
Rules for the relationship of the cardiovascular functional (FA) ability and maxi-
mal plasma creatine kinase values (CPK) in anteroseptal and inferior myocardial
infarction, obtained by means of the Cubist machine learning system (release 1.09)
Anteroseptal Myocardial Infarction Inferior Myocardial Infarction
Rule 1:
if
CPK > 564
then
FA = 76.92 – 0.0152 CPK
Rule 2:
if
CPK > 502
CPK  564
then
FA = 150.61 – 0.1301 CPK
Rule 3:
if
CPK  502
then
FA = 176.29 – 0.1675 CPK
Rule 1:
if
CPK > 914
then
FA = 97.73 – 0.0268 CPK
Rule 2:
if
CPK > 465
CPK  914
then
FA = 76.11 – 0.0138 CPK
Rule 3:
if
CPK  465
then
FA = 99.9 – 0.0489 CPK
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CPK<477.5
FA<69.15
FA<64.1
CPK<1879.5 CPK<808
FA<67.6
FA<65.55
CPK<726
Inferior
Anteroseptal Inferior
Inferior Anteroseptal
Anteroseptal
Inferior
Inferior
Anteroseptal
Figure 2. Classification tree discriminates between the groups of patients with an-
teroseptal and inferior localisation of the myocardial infarction on the basis of CPK
and cardiovascular functional ability parameters. Low misclassification error rate of
0.0357 (2 cases misclassified out of 56), low residual mean deviation of 0.1492 and
jack-knife testing of the procedure (mean error 2.03, SE 1.96) confirm the validity of
the tree and parameter dependence.
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Figure 1. Correlation of the cardiovascular functional ability for the real and Cubist
predicted values in anteroseptal and inferior myocardial infarction. Leave-one-out
cross-validation procedure for the anteroseptal and inferior localisation had average
errors of 1.72 and 3.54, relative errors of 0.14 and 0.41, and correlation coefficient (r)
of 0.98 and 0.85, respectively.
sive partitioning.10 The S-Plus 2000 software package was used for this type
of statistical analysis.10
The rules obtained by means of the Cubist machine learning procedure
provide accurate prediction of the cardiovascular functional ability following
the anteroseptal and inferior myocardial infarction on the basis of routine
CPK determination during the acute phase of the disease. The presented
method, therefore, represents a potent predictive tool for the clinical and ex-
perimental trials in Cardiology. In addition to its prognostic (and diagnostic)
applications, the extracted algorithms enable a more efficient evaluation of
new drugs and therapeutic procedures for the myocardial infarction.
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SA@ETAK
Vrijednosti kreatin-kinaze plazme i kardiovaskularna
funkcijska sposobnost u infarktu miokarda
Nikola [tambuk i Pa{ko Konjevoda
Najvi{e vrijednosti kreatin-kinaze plazme (CPK) ~esto se rabe kao enzimski test
u akutnom infarktu miokarda. Kardiovaskularna funkcijska sposobnost (FA) pouz-
dan je ~imbenik kojim se mo`e definirati o{te}enje krvo`ilnog sustava nakon infark-
ta. Program strojnog u~enja Cubist uporabili smo za izradbu modela koji s pomo}u
najvi{e izmjerene vrijednosti CPK tijekom akutnog infarkta miokarda definira osta-
tnu kardiovaskularnu funkcijsku sposobnost nakon infarkta. Cubist modelira nume-
ri~ke pokazatelje i generira vrijednosti s pomo}u skupa pravila koja lineariziraju
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zadani skup. Koriste}i se u literaturi navedenim podacima mjerenja Miri}a i sur.1, s
pomo}u programa Cubist izra|en je i testiran precizan model od tri jednostavna pra-
vila odnosa spomenutih pokazatelja u akutnom infarktu miokarda. Pravila omogu-
}uju jednostavno predvi|anje ostatne funkcijske sposobnosti krvo`ilnog sustava na-
kon oporavka od infarkta. Model se zasniva na dva klini~ka pokazatelja povezana s
bole{}u, najvi{im vrijednostima CPK na po~etku bolesti te anteroseptalnom ili infe-
riornom lokalizacijom infarkta. To~nost modela i mogu}nost njegove primjene u kli-
ni~koj medicini potvr|ena je visokom korelacijom (r (anteroseptalni) = 1,00, r (infe-
riorni) = 0,94; n = 56) te minimalnim razlikama izme|u stvarno izmjerenih i mode-
lom predvi|enih vrijednosti, kao i vrlo niskom pogre{kom modela izmjerenom testom
unakrsne validacije (anteroseptalni 1,72, inferiorni 3,54). Pored prognosti~kih i di-
jagnosti~kih primjena, izdvojena pravila omogu}uju i u~inkovitiju procjenu novih
kardiolo{kih lijekova i terapijskih postupaka.
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